【摘要】 目的 探讨α连环素(αcat)和β连环素(βcat)在非小细胞肺癌(NSCLC)中的表达及其与NSCLC的发生、发展及临床预后的关系。方法 应用免疫组化法,观察43例NSCLC患者及7例正常肺组织中的αcat和βcat的表达。结果 在43例NSCLC中,αcat和βcat的异常表达率分别为72.1%和65.1%;αcat、βcat异常表达与不同病理分级间和淋巴结有无转移均有显著性差异(P<0.05);αcat和βcat异常表达者的生存时间明显少于正常表达者,βcat异常表达具有独立的预后意义(P<0.05,相对危险度RR=0.330)。结论 αcat和βcat表达与NSCLC的发生、发展及预后关系密切,可作为评估NSCLC进展及预后的指标。
【关键词】 肺肿瘤;α连环素;β连环素;免疫组织化学
nonsmall cell lung cancer and their clinical significanceDANG Xiaomin, SUN Zhongmin, SHANG Dong
(Department of Respiration, the First Affiliated Hospital,
Medical School of Xian Jiaotong University, Xian 710061, China)ABSTRACT: Objective To investigate the expressions of αcatenin (αcat) and βcatenin (βcat) and their relation with development and prognosis of nonsmall cell lung cancer (NSCLC). Methods Expressions of αcat and βcat were immunohistochemically studied in 43 specimens of NSCLC and 7 cases of normal lung tissues. Results Of the 43 NSCLC cases, the abnormal rate of αcat and βcat expression was 72.1% and 65.1%, respectively. Differentiation and lymph node involvement had a significantly positive correlation with abnormal expression of αcat or βcat (P<0.05). The survival time was significantly shorter in patients with αcat or βcat abnormal expression than in those with normal αcat or βcat expression. βcat could serve as an independent prognosis factor (P<0.05). Conclusion The expressions of αcat and βcat are closely correlated with the occurrence, development and prognosis of NSCLC. αcat and βcat may be used as indicators for development and prognosis of NSCLC.
KEY WORDS: lung neoplasm; αcatenin; βcatenin; immunohistochemistry
上皮细胞钙依赖黏附分子E钙黏素(Ecadherin)主要介导上皮细胞之间的连接和黏附,Ecadherin主要位于细胞膜上,与细胞膜内侧的连环素α、β结合成复合体,Ecadherincatenin(Ecadcat)复合体中任何组分结构和功能的异常均会影响细胞的黏附性[1]。近年来发现Ecadcat复合体功能异常与恶性肿瘤的侵袭转移、预后密切相关[2]。为此,我们应用免疫组化方法观察了αcat、βcat在非小细胞肺癌(NSCLC)中的表达,并探讨其表达与NSCLC发生、发展及预后的关系。
[1] [2] [3] [4] [5] 下一页